Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CASI Pharmaceuticals (CASI) Treasury Shares (2021 - 2025)

Historic Treasury Shares for Pharmaceuticals (CASI) over the last 5 years, with Q2 2025 value amounting to -$9.6 million.

  • Pharmaceuticals' Treasury Shares rose 9990.0% to -$9.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$9.6 million, marking a year-over-year increase of 9990.0%. This contributed to the annual value of -$9.6 million for FY2024, which is 20000.0% down from last year.
  • Latest data reveals that Pharmaceuticals reported Treasury Shares of $2.0 million as of Q4 2024, which was up 38063.85% from $411952.0 recorded in Q4 2023.
  • Over the past 5 years, Pharmaceuticals' Treasury Shares peaked at $3.7 million during Q1 2022, and registered a low of $411952.0 during Q4 2023.
  • Over the past 4 years, Pharmaceuticals' median Treasury Shares value was $1.3 million (recorded in 2021), while the average stood at $1.7 million.
  • As far as peak fluctuations go, Pharmaceuticals' Treasury Shares crashed by 20000.0% in 2024, and later soared by 9990.0% in 2025.
  • Over the past 5 years, Pharmaceuticals' Treasury Shares (Quarter) stood at $8.0 million in 2021, then rose by 16.13% to $9.3 million in 2022, then rose by 2.94% to $9.6 million in 2023, then tumbled by 200.0% to -$9.6 million in 2024, then changed by 0.0% to -$9.6 million in 2025.
  • Its last three reported values are -$9.6 million in Q2 2025, -$9.6 million for Q4 2024, and -$9.6 billion during Q2 2024.